Form 483

Elevar Therapeutics, Inc. Form 483, 2026-05-20

FDA issued a Form 483 to Elevar Therapeutics, Inc. on 2026-05-20 with 1 public-safe observation.

483· Form 483 issuedHuman Drugs1 observation

Elevar Therapeutics, Inc. · Fort Lee, United States · Issued May 20, 2026

Overview

  • 1 public-safe observation is available for this inspection.
  • 1 structured CFR citation is represented.
  • 1 investigator is tied to this Form 483.

Inspectional observations

Each observation cites the regulation FDA found the firm out of compliance with.

20 May 2026
21 CFR 312.56(b)

Investigator non-compliance

Cited by Michael Serrano

Inspected site

ETElevar Therapeutics, Inc.Fort Lee, United States

Inspection team

Cited regulations

CFR citations associated with this Form 483.

CitationWhat it coversCited
21 CFR 312.56(b)Cited across public-safe Form 483 observations1x

Full 483 report

Get the verbatim text of all 1 observation

The full inspection record, as Atlas holds it, so your team sees exactly what was cited and how it was answered.

  • The site's full inspection history around this Form 483
  • Whether these citations escalated to a warning letter
  • The investigators involved and the citations they repeat elsewhere